The linearity of eukaryotic chromosomes presents challenges to cells, as the presence of DNA ''ends'' poses problems for the DNA replication machinery and the cell's damage response systems. This year's Nobel Prize in Physiology or Medicine recognized groundbreaking studies establishing the telomere field as a crucial area of biomedical research.
Human cells cannot live forever . or can they? The mortality of human cells is determined in large part by a fascinating region of the chromosome, the chromosomal terminus or telomere, whose small size ($0.027% of the human genome) belies its disproportionate influence on chromosome stability. Telomeres and their propensity to shorten with advancing age have been implicated in aspects of aging and in the chromosomal instability associated with human cancer. This year's Nobel Prize in Physiology or Medicine recognized the pioneering work of Elizabeth Blackburn, Carol Greider, and Jack Szostak in defining telomeres-their DNA composition, their specialized mode of DNA synthesis, and what happens when they are lost. Here, we highlight the key findings recognized by this prize and how they engendered a vibrant research field that is providing new insights into human health and disease.
The Backdrop-A Key Observation about Chromosome Behavior and a Biochemical Puzzle The defining property of telomeres was deduced in the 1930s by careful observation of chromosomes, before the discovery that genes are encoded by DNA. In studies of the damage inflicted by X irradiation of fruit flies and maize, respectively, Muller and McClintock each observed that Xray-induced chromosome breaks resulted in seemingly random joining reactions between the broken ends, in turn causing chromosomal rearrangements. Curiously, however, the original or ''natural'' chromosome ends were impervious to these joining reactions, implying that chromosome ends have some property that sets them apart from damage-induced breaks and preserves their intactness. The term ''telomere'' was first applied to these natural ends by Muller, who conceived of them as protective terminal genes. Moreover, McClintock found that in specific cell types (those of young embryos, which we now know are among the few cell types that express robust levels of telomerase), new impervious ends, i.e., new telomeres, could be formed at sites of breakage. These landmark ideas set the stage for the molecular definition of telomeres and how they are formed.
We now teleport to the 1970s, when a sticky implication of the newly discovered mechanism of DNA replication was grasped by Olovnikov and Watson. The fundamental properties of DNA polymerases cause a problem when the replication machinery reaches the end of the long linear DNA molecules that comprise eukaryotic chromosomes: first, the chemistry of DNA synthesis, in which DNA polymerases add nucleotides to a pre-existing 3 0 hydroxyl group, constrains its progression to the 5 0 to 3 0 direction. Likewise, DNA polymerases cannot synthesize DNA de novo-they need to extend pre-existing RNA primers, which are later removed and replaced by fill-in extension of adjacent Okazaki fragments. Moreover, DNA polymerases require a template to copy. Hence, removal of the RNA primer initiating the ultimate chromosomal Okazaki fragment creates a recessed 5 0 end whose fill-in synthesis cannot be primed, and replication of the resulting 3 0 overhanging duplex suffers as the leading strand replication machinery lacks a template for duplicating the overhang. This predicament, known as the end replication problem, leads to a small but inexorable loss of DNA from the chromosome end with each round of replication, and was recognized to have the potential to slowly erode our genetic information.
The Surprising Solution to the End Replication Puzzle Heralds the Molecular Definition of the Telomere The solution to the end replication puzzle awaited the feats of this year's Nobel Prize in Physiology or Medicine winners. Their work exploited simple model systems that confer significant experimental advantages, and its profound impact underscores the relevance of such models and the powerful genetic and biochemical approaches they afford to understanding complex issues vital to human health. Elizabeth Blackburn, then a postdoc in Joe Gall's laboratory, made the first breakthrough by sequencing the telomeres of the ciliated pond organism Tetrahymena thermophila. The monumental task of honing in on a rare and small sequence using the techniques available at that time was simplified by a remarkable feature of Tetrahymena and other ciliates: these organisms contain two nuclei, the germline micronucleus, which houses the ''master copy'' of the genome and is kept silent during vegetative growth, and the expressed macronucleus. In the macronucleus, the genome is fragmented into small, often gene-sized linear pieces, each of which acquires a telomere at either end. These pieces are then amplified, resulting in up to 50 million telomeres per macronucleus in some ciliates and a consequently enriched source of telomeric components. Blackburn and Gall studied the Tetrahymena macronuclear rDNA genes, which are carried on multiple ($20,000) separate linear molecules of roughly uniform length, each carrying a pair of rDNA sequences flanked on either side by telomeres. This abundance and uniformity allowed Blackburn and Gall to ascertain that each rDNA molecule terminated with 200-400 bp of tandem repeats of the hexanucleotide TTGGGG, and subsequent work suggested that such termini may not be limited to rDNA molecules (Blackburn and Gall, 1978) .
The generality and importance of telomere repeats per se, and G-rich telomeric repeats in particular, became apparent when Blackburn collaborated with Jack Szostak, who sought to figure out how artifical linear mini-chromosomes could be maintained in the budding yeast Saccharomyces cerevisiae. While the ends of introduced linear DNA molecules are generally susceptible to both recombination (resulting in their integration into homologous sites on endogenous chromosomes) and exonucleolytic degradation, the addition of Tetrahymena telomeric repeats to such linear DNA molecules allowed them to be stably maintained throughout many generations as nonintegrated, artificial chromosomes. Revealingly, the terminal fragments of these linear molecules were lengthened by $200 bp upon introduction into yeast. These results provided Szostak and Blackburn with a powerful tool for cloning the endogenous budding yeast telomeres-they screened for restriction fragments of yeast DNA that could impart the same stabilization of linear mini-chromosomes conferred by Tetrahymena telomeres. Strikingly, the identified yeast telomere sequences, comprising tandem repeats of (TG 1-3 ), were shown to be added by yeast cells to the ends of the introduced Tetrahymena repeat stretches, accounting for the elongation of their terminal restriction fragments (Szostak and Blackburn, 1982) .
Hence, Blackburn and Szostak had found extraordinary conservation of those features that confer faithful replication and maintenance of telomeres. They showed that ciliates and yeast, despite representing different kingdoms within eukarya, both harbor tandemly repeated G-rich terminal sequences, foreshadowing the identification of related sequences in nearly all eukaryotes (e.g., the vertebrate telomere repeat is TTAGGG). Moreover, they showed that yeast cells treat such repeats very distinctly from the way they treat random terminal sequences, adding further telomeric repeats to them rather than degrading, fusing, or recombining them with other sequences. Nonetheless, a constellation of burning questions remained. For instance, what biochemical activity would explain this telomere sequence addition and keep telomeres immune from the end replication problem?
The surprising answer to this question emerged from biochemical characterization of the activity responsible for synthesizing telomeres in Tetrahymena-the work of Blackburn and her graduate student, Carol Greider. The addition of yeast telomeres to Tetrahymena telomeric ''seeds'' had suggested an activity that could synthesize telomere repeats de novo, rather than adding them through recombinational copying from one telomere repeat stretch to another, a competing hypothesis at the time. Greider and Blackburn surmised that this activity would be abundant in Tetrahymena undergoing macronuclear development-the period during which the genome is fragmented and amplified, necessitating the addition of telomeres to the tens of thousands of newly formed minichromosomes. Indeed, after refining extraction protocols and the choice of a ''telomere-mimicking'' substrate-an oligonucleotide of telomeric sequence (TTGGGG)-on which to assess telomere addition, an activity was found that added quantized stretches of DNA corresponding to multiples of the 6-nucleotide telomere repeat. This activity failed to extend the complementary (CCCCAA) oligonucleotide and was enriched during macronuclear development, as would be expected for a telomere-specific synthesizing activity. Furthermore, it was capable of adding Tetrahymena repeats to an oligonucleotide comprising the yeast telomere sequence, mirroring the converse activity shown by budding yeast cells and proving that the activity was not simply copying the input oligonucleotide. The activity was termed ''telomerase'' (Figure 1 ) (Greider and Blackburn, 1985) .
The next major revelation came from deciphering the nature of the molecule used as a template by telomerase. Greider and Blackburn found that telomerase activity was inactivated by treatment with RNase A, indicating that it relied on an RNA molecule. Moreover, the relevant RNA component turned out to contain the precise sequence that would, by base-pairing The telomerase reverse transcriptase (TERT) catalytic protein subunit adds telomere repeats to the 3 0 ends of chromosomes using the telomerase RNA subunit (TERC) as a template for telomere repeat synthesis. Newly added nucleotides are depicted by blue italic letters. Telomeres provide binding sites for the subunits of shelterin (represented by light-blue ellipses), which protects chromosome ends from activating the DNA-damage response and regulates telomerase.
with the pre-existing telomeric oligonucleotide ''seed,'' position the telomerase RNA and provide the template for elongation of the ''seed'' by the addition of new telomeric repeats (Greider and Blackburn, 1989) . These observations implied that telomerase was a reverse transcriptase that utilizes its own RNA subunit as a template for DNA synthesis (Figure 1 ). This idea was verified in elegant experiments in which mutation of the template region of the telomerase RNA led to synthesis of correspondingly mutated telomeric repeats (Yu et al., 1990) .
In a legendary confluence of biochemical and genetic approaches, the characterization of ciliate telomerase was complemented by a genetic screen carried out in the Szostak lab. Lundblad and Szostak designed this screen to pinpoint mutants conferring a predicted telomerase-minus phenotype: gradual loss of chromosomal termini due to the end replication problem, but immediate loss of the ability to add telomeres to acutely introduced telomeric seeds. To accomplish this acute introduction, they developed a circular plasmid whose breakage, linearization, and stabilization via telomere addition to either end could be induced and monitored using a combination of markers for positive and negative selection. This screen, known as the evershorter telomeres or EST screen, identified EST1, and later EST2, EST3, and EST4 (Lundblad and Szostak, 1989) . All of these genes are required for telomerase activity in vivo, and one of them, EST2, was shown to encode the yeast ortholog of the ciliate telomerase catalytic protein subunit. Crucially, the EST phenotype demonstrated the in vivo consequences of telomerase inactivation: progressive telomere loss followed by the cessation of cellular growth or senescence.
Reverberations of the Solution
These fundamental discoveries set the stage for more in-depth analyses of telomere biology in model organisms and humans, leading to major new insights into cellular immortality, cancer, and stem cell biology. Replicative Senescence and a Mitotic Clock in Human Cells Senescence in human cells had been described even earlier, although the cause remained obscure until telomeres were molecularly defined. Unlike cancer cell lines, primary human fibroblasts were found to enter a state of irreversible growth arrest termed replicative senescence after 60-80 population doublings (Hayflick and Moorhead, 1961) . The long delay before the onset of replicative senescence led to the suggestion that telomere shortening due to the end replication problem could underlie senescence (Figure 2) . Indeed, once the human In cells with insufficient telomerase, DNA replication-dependent telomere attrition results in critically short telomeres, which activate the DNA-damage response, leading to senescence or apoptosis. However, in cells lacking a robust DNA-damage checkpoint response, inappropriate ''repair'' reactions act on telomeres. One result of this is the end fusion depicted, which produces a dicentric chromosome that breaks randomly if the centromeres are pulled to opposite poles by the mitotic spindle. This scenario can lead to cell death or to widespread chromosomal rearrangement through cycles of chromosomal fusion and breakage, which can drive tumor development. Telomerase upregulation (or, rarely, an alternative telomere maintenance pathway) stabilizes the telomeres, allowing the propagation of aberrant genomes associated with many cancers.
telomere repeat was defined as TTAGGG, analysis of cultured human fibroblasts showed that telomeres in fact shorten with cell division. These observations provided evidence in support of a ''counting mechanism'' in which telomere length provides an indication of the replicative history of certain human cells. This ''mitotic clock'' is not limited to human fibroblasts in culture; telomere shortening is seen in human tissues with advancing age, suggesting that short telomeres may contribute to the aging process as well as certain age-related disease states. Telomeres and the DNA-Damage Response: A Love-Hate Relationship How does telomere shortening lead to replicative senescence? The answer lies in the fundamental role of telomeres in suppressing DNA damage responses at chromosome ends. Mammalian telomeres are bound by a multisubunit protein complex termed shelterin, the study of which has been pioneered by Titia de Lange's laboratory (de Lange, 2005); a highly similar complex binds fission yeast telomeres, and a related complex binds budding yeast telomeres. Shelterin comprises proteins that bind to the doublestranded telomeric repeats, the single stranded 3 0 overhang, and the telomerebinding proteins themselves. These proteins control the accessibility of telomeres to nucleases and telomerase, prevent telomeres from engaging in end-joining reactions or undergoing extensive recombination, and prevent telomeres from activating DNA-damage checkpoints and arresting cell-cycle progression. Interfering with individual shelterin components erodes this program of controlled telomeric access. For instance, the results of loss of mammalian TRF2 or fission yeast Taz1 include lethal chromosome end fusions. In addition, shelterin mutants can suffer excessive telomeric resection, telomere length changes, excised telomeric circle formation and/or cell cycle arrest, depending on precisely which shelterin component(s) are compromised and what cell-cycle stage the cells are experiencing (Rog and Cooper, 2008; de Lange, 2009) .
Hence, at first glance, it might seem rational for shelterin to protect telomeres by excluding nucleases, recombination enzymes, nonhomologous end-joining factors, and the checkpoint machinery. However, not only are all of these activities found at least periodically at telomeres, but also they play important roles in telomere protection and telomerase activation. For example, telomerase can only extend telomeres that contain 3 0 overhangs, but leading strand replication results in blunt-ended duplexes. Therefore, telomeres must engage nucleases to resect the 5 0 strand at these blunt ends, while at the same time avoiding overzealous resection (which would ultimately remove the double-stranded telomeric region and associated shelterin components). Moreover, the checkpoint kinases ATM and ATR play crucial roles in telomerase activation (at least in fission yeast and budding yeast), despite the fact that robust telomeres prevent these kinases from phosphorylating substrates that confer checkpoint activation. Thus, the relationship between telomeres and repair pathways is an intimate one in which telomeres carefully control the activity of these pathways to facilitate replication, while preventing a full damage response (Rog and Cooper, 2008; de Lange, 2009) .
Just as interference with telomerebinding proteins leads to telomere dysfunction, the inexorable shortening of telomeres that occurs as human fibroblasts divide in cell culture results in telomere uncapping (Shay and Wright, 2005) . As primary human cells reach replicative senescence, DNA damage foci are seen coincident with telomeres at a subset of chromosome ends. These telomere dysfunction-induced foci (TIFs) are presumably responsible for activating the p53 and Rb tumor-suppressor pathways, which enforce replicative senescence in human cells. Inactivation of p53 and Rb in human fibroblasts prevents replicative senescence and allows cells to continue dividing. In this setting of deactivated checkpoints, telomeres shorten further and are ligated to yield fused chromosomes. This state of severe chromosome instability and cell death is known as telomere-based crisis and has important significance in cancer development (Figure 2) . Telomerase, Immortalization, and Cancer Despite the conservation of function of telomerase across eukaryotes, cloning the protein components of telomerase was a significant challenge. The critical breakthrough in this regard was a biochemical purification strategy using the ciliate Euplotes aediculatus. Lingner and Cech devised an approach using an antisense oligonucleotide column with complementarity to the template region of the telomerase RNA to enrich for telomerase complexes. Analysis of the purified proteins by mass spectrometry led to the identification of Euplotes TERT (telomerase reverse transcriptase) and to the realization that Est2p, isolated in the yeast EST screen, was the yeast catalytic telomerase component (Lingner et al., 1997) . With these TERT genes in hand, the human TERT gene was identified by homology, and it became clear that all TERT proteins share a common set of reverse transcriptase motifs, consistent with the original discovery of the telomerase enzyme as a reverse transcriptase by Greider and Blackburn.
The advent of a sensitive, PCR-based telomerase enzymatic assay (the telomerase repeat amplification protocol, or TRAP, assay) for mammalian cell extracts allowed telomerase expression patterns to be studied in cell lines, tissues, and cancers. Telomerase activity was shown to be associated with human cancers, immortal cell lines, and male germ cells, but undetectable in primary human fibroblasts, which undergo telomere shortening and eventual senescence. Analysis of TERT mRNA expression revealed that TERT was expressed in all immortal, telomerase positive cell lines but not in primary human fibroblasts, suggesting that TERT was the regulated component dictating telomerase competence. In a landmark experiment, stable overexpression of TERT in primary human fibroblasts reconstituted telomerase, lengthened telomeres, and rendered these cells immortal (Bodnar et al., 1998) . These experiments clearly and causally linked the senescence of human fibroblasts to telomere shortening, and provided a strong connection between telomerase and the immortality of cancer cells.
Lessons from Mice: Links to Tissue Progenitor Cells and Cancer
The generation of mice deficient in the telomerase RNA component, TERC, by the Greider and DePinho labs allowed the study of telomeres to be extended from unicellular eukaryotes and cultured human cells to a complex multicellular mammal in vivo. TERC À/À mice were viable in early generations because they retained long and functional telomeres (telomeres in mice are four to five times longer than in humans). However, telomeres shorten progressively with each additional generation of telomerase deficiency. In the fifth and sixth generations (G5-G6), a subset of telomeres become critically short and are ligated to generate fused chromosomes. These events have profound effects on highly proliferative tissues that depend upon stem and progenitor cells for their maintenance and repair. In the context of a tissue, telomere dysfunction preferentially affects these cycling precursor cells, impairing both progenitor cell survival and stem cell self-renewal. At the level of the whole organism, critically short telomeres precipitate a premature aging phenotype, highlighting the potential importance of telomeres in organismal aging.
How does telomere dysfunction impair tissue progenitor cell function? Progressive telomere attrition in these cells activates a DNA-damage response that converges on p53, much like in human fibroblasts. In fact, genetic ablation of p53 in G5-G6 TERC À/À mice blunted cell death responses and improved the function of proliferative tissues. This central role for p53 in surveying dysfunctional telomeres suggests an important link to cancer, as had been suggested by the human fibroblast cell culture model and the observation that telomeres shorten substantially during early tumorigenesis. The associated hypothesis predicted that telomere shortening in incipient cancers with insufficient telomerase would induce senescence and apoptosis, thereby acting as a potent brake on tumor development, unless telomerase was upregulated to restore telomere function. Extensive work on cancer development in telomerase knockout mouse strains provided support for this model-but only in part. It turns out that the status of p53 dictates how dysfunctional telomeres influence carcinogenesis (Artandi and Depinho, 2009 (Figure 2 ). This chromosome instability leads to chromosome translocations, focal gene deletions, and amplifications that provide selection for a malignant genotype capable of promoting tumor initiation and progression. In humans, telomerase upregulation late in tumor development is critical for stabilizing telomeres, quelling chromosome instability and promoting immortal cell division. Indeed, the requirement for telomerase in mature tumor cells was verified by experiments showing that TERT is essential for transforming human fibroblasts in culture.
A Human Genetic Disease of Telomerase Deficiency
The link between telomere shortening and progenitor cell dysfunction identified in telomerase knockout mice presaged the finding that the pathology of a human genetic disease is driven by a similar mechanism. Dyskeratosis congenita (DC) is a multisystemic disorder characterized by defects in skin, blood, and lung, among other tissues. DC patients suffer predominantly from aplastic anemia-a failure of blood stem cellsand pulmonary fibrosis, a condition associated with loss of pulmonary epithelium and an overactive fibrosis response (Walne and Dokal, 2009 
